IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $628,000 | +13.2% | 32,292 | -3.2% | 0.01% | +42.9% |
| Q4 2017 | $555,000 | -24.0% | 33,344 | -42.2% | 0.01% | -22.2% |
| Q1 2017 | $730,000 | +1.0% | 57,730 | +5.8% | 0.01% | +28.6% |
| Q4 2016 | $723,000 | +91.3% | 54,574 | +242.2% | 0.01% | +40.0% |
| Q3 2016 | $378,000 | +18.1% | 15,947 | +43.5% | 0.01% | +25.0% |
| Q2 2016 | $320,000 | -8.0% | 11,111 | +36.6% | 0.00% | -55.6% |
| Q4 2015 | $348,000 | -41.6% | 8,136 | -51.9% | 0.01% | -35.7% |
| Q3 2015 | $596,000 | +179.8% | 16,923 | +264.2% | 0.01% | +250.0% |
| Q2 2015 | $213,000 | -65.9% | 4,646 | -65.1% | 0.00% | -77.8% |
| Q1 2015 | $624,000 | -35.5% | 13,307 | -56.4% | 0.02% | -57.1% |
| Q4 2014 | $967,000 | +327.9% | 30,529 | +257.6% | 0.04% | +180.0% |
| Q1 2014 | $226,000 | -36.3% | 8,538 | -50.6% | 0.02% | +7.1% |
| Q3 2013 | $355,000 | – | 17,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,032,187 | $24,463,000 | 8.84% |
| Asymmetry Capital Management, L.P. | 164,156 | $3,890,000 | 6.76% |
| Hound Partners | 6,204,588 | $147,049,000 | 3.96% |
| Sivik Global Healthcare LLC | 130,000 | $3,081,000 | 1.55% |
| Tradewinds Global Investors, LLC | 49,661 | $1,177,000 | 1.45% |
| SECTOR GAMMA AS | 409,964 | $7,318,000 | 1.28% |
| Orbimed Advisors | 3,787,500 | $89,764,000 | 1.02% |
| Iguana Healthcare Management, LLC | 200,000 | $4,740,000 | 0.84% |
| Seven Bridges Advisors LLC | 37,409 | $887,000 | 0.79% |
| Penn Capital Management Company, LLC | 454,597 | $10,808,000 | 0.73% |